1. Home
  2. SLDP vs AVIR Comparison

SLDP vs AVIR Comparison

Compare SLDP & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Power Inc.

SLDP

Solid Power Inc.

HOLD

Current Price

$2.47

Market Cap

463.5M

Sector

Energy

ML Signal

HOLD

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$5.29

Market Cap

429.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDP
AVIR
Founded
2011
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
463.5M
429.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
SLDP
AVIR
Price
$2.47
$5.29
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$7.00
$10.00
AVG Volume (30 Days)
2.2M
216.2K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
5.56
3.00
EPS
N/A
N/A
Revenue
$21,747,000.00
$351,367,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$48.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.98
N/A
52 Week Low
$1.98
$2.78
52 Week High
$8.86
$6.45

Technical Indicators

Market Signals
Indicator
SLDP
AVIR
Relative Strength Index (RSI) 52.98 48.40
Support Level $2.22 $5.13
Resistance Level $2.50 $5.79
Average True Range (ATR) 0.11 0.20
MACD 0.00 -0.06
Stochastic Oscillator 53.57 25.56

Price Performance

Historical Comparison
SLDP
AVIR

About SLDP Solid Power Inc.

Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Share on Social Networks: